| Home | Site Map | This Site Is For Sale | Powered by WhyPark.com | ||
| AnyInfo.com | ||
|
New Guide Will Help Pharmaceutical Companies Obtain Reimbursement in the Asia Pacific Markets
(PRWEB) July 6, 2008 -- Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report offering pharmaceutical companies a comprehensive guidance to the reimbursement situation in all major markets in the Asia Pacific region.
The report "Pricing & Reimbursement in Asia Pacific", which is available at http://tinyurl.com/5lw2u8 provides key information allowing the reader to ensure that the company's products are reimbursed by the appropriate government agency or health insurer.
Divided into specific country sections, each chapter of the report gives a detailed insight into who is responsible for reimbursement as well as the processes for assessing a drug's suitability for reimbursement in each individual country. It includes information about recent changes, government policy on healthcare costs and expected changes in the near future within the country.
This new report offers the reader: - An overview of the reimbursement procedures in Asia Pacific - Information on payment bodies - An outline of the recent changes to reimbursement regulation - Government policy - Generic substitution - Predictions of future reforms to enable you to develop future strategy
The report "Pricing & Reimbursement in Asia Pacific" is available in pdf format from Piribo:
Piribo product ID: SCR020
About Piribo. Piribo (http://www.piribo.com/publications/regulation_policy) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 9,000 English language titles including, market reports, studies and books and is the UK's largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.
###
This press release has been reprinted from PRWEB per the terms and conditions of the copyright notice.
|
| Home | Site Map | This Site Is For Sale | Powered by WhyPark.com |